The Use of Somatropin (Recombinant Growth Hormone) in Children of Short Stature

@article{Mehta2002TheUO,
  title={The Use of Somatropin (Recombinant Growth Hormone) in Children of Short Stature},
  author={Ameeta Mehta and Peter C Hindmarsh},
  journal={Pediatric Drugs},
  year={2002},
  volume={4},
  pages={37-47}
}
The availability of somatropin [recombinant human growth hormone (GH)] has revolutionized the treatment of short stature resulting from GH deficiency. It is also widely used as an adjunct in the treatment of other disorders which do not fit the definition of classic GH deficiency, such as intrauterine growth restriction, Turner syndrome, healthy children with short stature and skeletal dysplasias.The widespread use and ready availability of GH treatment has prompted questions about its… Expand
Growth hormone therapy in children and adults.
TLDR
The aim of this paper is to summarize the current data on GH administration in modern pharmacotherapy, including the results of the recently published studies and discussed not commonly known indications for GH therapy, as well as its experimental administration in both children and adults. Expand
Growth hormone therapy and Quality of Life: possibilities, pitfalls and mechanisms.
TLDR
This paper analyses studies investigating the relationship between GH and QoL in GH-deficient children or adults, inGH-replete short children suffering from idiopathic short stature, Turner syndrome, or intrauterine growth retardation and in GH -deficient or replete elderly adults. Expand
Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance.
TLDR
An overview of the different technologies and routes of GH administration is provided and the principles, limitations and pharmacological profiles for each approach are discussed. Expand
Recombinant Human Growth Hormone Treatment after Liver Transplantation in Childhood: The 5-year Outcome
TLDR
The efficacy of rhGH treatment is sustained after the first year in liver-transplant children with non–GH-deficient growth retardation after liver transplantation, and close monitoring of these patients is required. Expand
Does aerobic exercise affect the hypothalamic-pituitary-adrenal hormonal response in patients with fibromyalgia syndrome?
TLDR
The results of this study seem to support the hypothesis that there is a dysregulation of the HPA axis in patients with FM, and that a six-week exercise program can influence symptoms and affect the H PA axis hormones. Expand
Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument
TLDR
The QoLISSY questionnaire is a promising step forward in assessing the impact of dSS on HrQoL, based on items generated from the subjective experience of short stature children referred for endocrine investigation, is validated for use in five languages and easy to administer in clinical and research settings. Expand
Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
TLDR
It is suggested that CNP administration stimulates skeletal growth without adverse cardiovascular effect, and thus CNP could be a promising remedy targeting achondroplasia. Expand
A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs.
TLDR
Results demonstrate that pGHRH transfer is effective for promoting growth and avoids the need for the frequent injections necessitated with peptide hormone use. Expand
Pharmacologic Approaches to the Aging Athlete
TLDR
While the process of aging has become better understood leading to more rational approaches to combat its effects on health, the clinician is reminded to carefully discern between the science and marketing that is available in this area. Expand
Psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the Netherlands
TLDR
The Dutch QoLISSY questionnaire is a psychometrically reliable and valid short stature-specific quality of life measure reflecting the child and parent perspectives and can be used as a treatment outcome indicator in research and practice. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 78 REFERENCES
The effects of treatment combining an agonist of gonadotropin-releasing hormone with growth hormone in pubertal patients with isolated growth hormone deficiency.
TLDR
It is concluded that combination of the long-acting Trp6-GnRH analogue and GH for 1-2 years in patients with isolated growth hormone deficiency whose puberty starts with a very insufficient height may be an appropriate way to improve their growth parameters. Expand
Growth and Growth Hormone Therapy in Hypochondroplasia
TLDR
Biosynthetic growth hormone in doses between 12‐32 u/m2/week produced a significant acceleration in height velocity standard deviation score (SDS) for chronological age (CA) from a pretreatment mean of ‐ 1.66 (SD 1.36) to + 1.62 ( SD 1.52) (p < 0.001). Expand
Spontaneous Growth and Response to Growth Hormone Treatment in Children with Growth Hormone Deficiency and Idiopathic Short Stature
TLDR
In untreated boys with ISS the mean final height was 2-5 cm lower than that predicted before puberty, whereas in girls it was almost equal to the prediction, and preliminary data suggest that on present regimens means final height may approach target height. Expand
Metabolic Consequences of Growth Hormone Treatment in Paediatric Practice
  • P. Saenger
  • Medicine
  • Hormone Research in Paediatrics
  • 2000
TLDR
The hyperinsulinaemia observed during GH therapy may amplify the anabolic effects of insulin on protein metabolism during puberty, which may lead to prolongation of the physiological state of insulin resistance observed in normal puberty. Expand
Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height
TLDR
A large, previously unreported, clinical trial of GH treatment in Turner syndrome found that final height is improved and the age at which feminization is induced could be an important factor in determining the patient’s ultimate growth response. Expand
Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.
TLDR
Year-1 growth response, expressed as growth rate or change in height SD score, was the best predictor of growth in subsequent years, and Responses to therapy could not be reliably predicted from baseline anthropometric variables, plasma insulin-like growth factor ISD score, growth hormone levels. Expand
The effects of growth hormone therapy on spontaneous sexual development.
TLDR
The data suggest that both boys and girls had a more rapid rate of pubertal maturation than normal and may be that in terms of final height prognosis, the events of puberty related to GH treatment counterbalance the improvement in growth prognosis during prepuberty. Expand
Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency.
TLDR
The preliminary data showed that the addition of GnRH-analogues to GH in subjects with isolated GH deficiency reduces the effect of GH on height velocity, but determines an improvement in statural prognosis, although a proper answer will not be obtained until final height has been achieved. Expand
Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency.
TLDR
It is indicated that for boys with non-GH-deficient short stature GH therapy does not improve height SDS for bone age during the prepubertal period, and in fact reduces it during the pubertalperiod, possibly resulting in a shorter final height than might have been attained naturally. Expand
Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone.
TLDR
These data show that in patients, combined treatment with GnRH analog and GH, despite a significant improvement in PH during therapy and upon its withdrawal, does not result in a significant increase in adult stature. Expand
...
1
2
3
4
5
...